Ausgabe 5/2004
Inhalt (12 Artikel)
In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances
Ritsuko Ishii, Masumi Shimizu, Yohko Nakagawa, Kazuo Shimizu, Shigeo Tanaka, Hidemi Takahashi
Identification of a MHC class-II restricted epitope in carcinoembryonic antigen
Lei Shen, Roland Schroers, Juergen Hammer, Xue F. Huang, Si-Yi Chen
Effect of albumin fusion on the biodistribution of interleukin-2
Zhengsheng Yao, Weili Dai, James Perry, Martin W. Brechbiel, Cynthia Sung
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies
Pamela J. Russell, Dean Hewish, Teresa Carter, Katy Sterling-Levis, Kim Ow, Meghan Hattarki, Larissa Doughty, Robin Guthrie, Deborah Shapira, Peter L Molloy, Jerome A. Werkmeister, Alexander A. Kortt
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
Deanne M. R. Lathers, Joseph I. Clark, Nicholas J. Achille, M. Rita I. Young
Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
Alexander Fosså, Lene Alsøe, Reto Crameri, Steinar Funderud, Gustav Gaudernack, Erlend B. Smeland
Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro
Ida Aagård Hedfors, Jan E. Brinchmann
Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma
Halina Kusnierczyk, Elzbieta Pajtasz-Piasecka, Jan-Willem Koten, Caspaar Bijleveld, Krzysztof Krawczyk, Willem Den Otter
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
Benoît Barrou, Gérard Benoît, Mahmoud Ouldkaci, Olivier Cussenot, Margarita Salcedo, Sudhanshu Agrawal, Séverine Massicard, Nadège Bercovici, Mats L. Ericson, Nicolas Thiounn
Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B
Hyoung-Ran Kim, Hyun-Joo Park, Jeon Han Park, Se Jong Kim, Kunhong Kim, Jongsun Kim
British Society for Immunology annual congress, Harrogate, UK, 2–5 December 2003
Graham Pawelec